More than 75 emerging biotechs use veeva basics across clinical, regulatory, and quality

Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies pleasanton, calif. , may 20, 2025 /prnewswire/ -- veeva systems (nyse: veev) today announced that veeva basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality.
VEEV Ratings Summary
VEEV Quant Ranking